GO
Loading...

Dendreon Corp

More

  • Dendreon declares bankruptcy  Monday, 10 Nov 2014 | 2:18 PM ET

    Joseph Pantginis, Roth Capital, has been negative on Dendreon for a long time, ahead of the drugmaker's bankruptcy protection filing.

  • Nov 10- Dendreon Corp filed for Chapter 11 bankruptcy protection after sales of the world's first cancer vaccine fell short of expectations and left the company deep in debt. Seattle- based Dendreon said it had agreed terms of a financial restructuring with certain bond holders that may involve a standalone recapitalization or the sale of the company or its...

  • Nov 10- Cancer vaccine maker Dendreon Corp filed for Chapter 11 bankruptcy protection on Monday after its potential blockbuster cancer drug failed to live up to expectations, saddling the company with heavy debt. Dendreon's stock was down nearly 62 percent at 36 cents in premarket trading. Under the agreements, senior noteholders will support a plan of...

  • Early Movers: RIG, GOGO, PFE, GM, TWX & more Monday, 10 Nov 2014 | 7:53 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Dendreon files for Chapter 11 bankruptcy Monday, 10 Nov 2014 | 2:22 AM ET

    Nov 10- Biotechnology company Dendreon Corp filed for chapter 11 bankruptcy protection on Monday and said it has reached agreements on the terms of a financial restructuring with certain bond holders. Dendreon said the restructuring may take the form of a stand-alone recapitalization or a sale of the company or its assets. Under the agreements, the senior...

  • Medicare agency focus of insider trading probes Wednesday, 29 Oct 2014 | 11:00 AM ET
    Department of Health and Human Services building, Washington.

    Federal authorities are investigating whether officials at the agency that runs Medicare leaked information that landed with Wall Street traders.

  • The SEC is pursuing three overlapping insider-trading investigations involving CMS, the report said, adding that one of the cases involves the Federal Bureau of Investigation. In one probe, the SEC is examining whether any agency officials tipped off policy research firm Marwood Group LLC about CMS's review of Dendreon Corp's prostate cancer treatment...

  • NEW YORK, Sept 12- Kenny G, the best-selling jazz musician who once played at President Bill Clinton's inaugural ball, wakes up every morning to Starbucks. Instead, the man whose real name is Kenny Gorelick obsessively checks the company's stock price.

  • Midday Movers: Kate Spade, Chevron, Insys & more Tuesday, 12 Aug 2014 | 12:33 PM ET
    Traders work on the floor of the New York Stock Exchange in New York.

    Take a look at some of Tuesday's midday movers:

  • Early movers: BEAV, KORS, S, FB, SNE, TWX & more Tuesday, 10 Jun 2014 | 7:49 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Believe in strong Europe reimbursement: Dendreon CEO  Wednesday, 5 Mar 2014 | 5:29 PM ET

    Biotech firm Dendreon is set to begin selling its prostate cancer vaccine "Provenge" in Europe. John Johnson, Dendreon chairman & CEO, discusses the European launch and addresses investor concerns.

  • Inside Ukraine's presidential pad and 'Ask Warren' Thursday, 27 Feb 2014 | 11:34 AM ET
    CNBC visits the palace of ousted Ukrainian President Viktor Yanukovych.

    This week on Talking Squawk: Tour some lavish digs, find out how you can ask Warren Buffett a question and get stock picks.

  • Midday stock movers: Netflix, Twitter, Express & More Monday, 13 Jan 2014 | 12:57 PM ET

    Some of Monday's midday movers:

  • Early movers: MRK, BKW, LORL, JPM, FB, BBRY & more Monday, 28 Oct 2013 | 7:35 AM ET

    Some of the names on the move ahead of the open.

  • Lightning Round: Ford, Five Below & More Monday, 23 Sep 2013 | 6:45 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Early movers: NDAQ, FL, P, GES, ARO, GS & more Friday, 23 Aug 2013 | 7:50 AM ET

    Some of the names on the move ahead of the open.

  • After-hours buzz: JCPenney, Priceline & more Thursday, 8 Aug 2013 | 5:13 PM ET

    Check out which companies are making headlines after the bell Thursday:

  • Midday Movers: BBY, THC & More Friday, 11 Jan 2013 | 12:51 PM ET

    Take a look at some of Friday's midday movers:

  • --Abiomed Inc rescheduled second-quarter conference call to Nov. 1 at 8 am Eastern Time. --Accelrys Inc rescheduled third-quarter results to Oct. 31, after market. Its conference call will be held on Nov. 1, 9.30 am Eastern Time.

  • --Acorda Therapeutics Inc: rescheduled third-quarter financial results and conference call to Oct. 31 from Oct. 30. --Advent Software Inc reschedules third-quarter results and conference call to Oct. 30. --AGCO Corp rescheduled third-quarter results to Oct 31, 8 am Eastern Time from Oct. 30.